Background: The prevalence of unruptured intracranial aneurysms (UIAs) increases rapidly in aging women compared with younger women. The impact of menopausal age on UIAs and treatment outcomes with endovascular therapy has not been well studied. We hypothesized that premenopausal age may have a protective effect on presentation size and treatment outcomes. Objective: To evaluate the association of menopause with UIA size and outcome with endovascular therapy. Methods: Retrospective analysis of consecutive female patients with UIAs treated with endovascular therapy at our academic tertiary care center. UIA characteristics, complications, and outcomes were recorded and compared. Results: 117 patients were included: 23 patients in the premenopausal age (PRM) group and 94 in the postmenopausal age (POM) group. 93.6% of all aneurysms in the PRM group were in the internal carotid artery (ICA) segments (p < 0.05). Hence only ICA segment aneurysms were further studied. A total of 21 patients in the PRM group and 60 in the POM group were found to have ICA segment aneurysms. Baseline characteristics were similar between the 2 groups. The mean size of the aneurysms in the PRM group was 8.6 ± 3.9 versus 10.8 ± 5.6 mm in the POM group (p = 0.055). There was a trend to higher aneurysm neck size seen in the POM group (4.7 ± 2.5 vs. 3.7 ± 1.7 mm; p = 0.07). The number of aneurysm lobes was higher in the PRM group (1.23 ± 0.54 vs. 1.07 ± 0.31; p = 0.18). In multivariate analysis, the PRM group had a significantly higher number of UIA lobes. Complications and endovascular therapy outcomes were similar between the 2 groups. Conclusions: A trend to increased UIA maximal diameter and neck size was seen in the POM group compared to the PRM group. The PRM group had a significantly higher number of UIA lobes. Larger prospective trials are needed to confirm these findings.

1.
Vlak
MH
,
Algra
A
,
Brandenburg
R
,
Rinkel
GJ
.
Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis
.
Lancet Neurol
.
2011
Jul
;
10
(
7
):
626
36
.
[PubMed]
1474-4422
2.
Stober
T
,
Sen
S
,
Anstätt
T
,
Freier
G
,
Schimrigk
K
.
Direct evidence of hypertension and the possible role of post-menopause oestrogen deficiency in the pathogenesis of berry aneurysms
.
J Neurol
.
1985
;
232
(
2
):
67
72
.
[PubMed]
0340-5354
3.
Kato
I
,
Toniolo
P
,
Akhmedkhanov
A
,
Koenig
KL
,
Shore
R
,
Zeleniuch-Jacquotte
A
.
Prospective study of factors influencing the onset of natural menopause
.
J Clin Epidemiol
.
1998
Dec
;
51
(
12
):
1271
6
.
[PubMed]
0895-4356
4.
Dhar
S
,
Tremmel
M
,
Mocco
J
,
Kim
M
,
Yamamoto
J
,
Siddiqui
AH
, et al.
Morphology parameters for intracranial aneurysm rupture risk assessment
.
Neurosurgery
.
2008
Aug
;
63
(
2
):
185
96
.
[PubMed]
0148-396X
5.
Beck
J
,
Rohde
S
,
el Beltagy
M
,
Zimmermann
M
,
Berkefeld
J
,
Seifert
V
, et al.
Difference in configuration of ruptured and unruptured intracranial aneurysms determined by biplanar digital subtraction angiography
.
Acta Neurochir (Wien)
.
2003
Oct
;
145
(
10
):
861
5
.
[PubMed]
0001-6268
6.
Brown
RD
 Jr
,
Broderick
JP
.
Unruptured intracranial aneurysms: epidemiology, natural history, management options, and familial screening
.
Lancet Neurol
.
2014
Apr
;
13
(
4
):
393
404
.
[PubMed]
1474-4422
7.
Brisman
JL
,
Song
JK
,
Newell
DW
.
Cerebral aneurysms
.
N Engl J Med
.
2006
Aug
;
355
(
9
):
928
39
.
[PubMed]
0028-4793
8.
Taylor
CL
,
Yuan
Z
,
Selman
WR
,
Ratcheson
RA
,
Rimm
AA
.
Cerebral arterial aneurysm formation and rupture in 20,767 elderly patients: hypertension and other risk factors
.
J Neurosurg
.
1995
Nov
;
83
(
5
):
812
9
.
[PubMed]
0022-3085
9.
Vlak
MH
,
Rinkel
GJ
,
Greebe
P
,
Algra
A
.
Independent risk factors for intracranial aneurysms and their joint effect: a case-control study
.
Stroke
.
2013
Apr
;
44
(
4
):
984
7
.
[PubMed]
0039-2499
10.
Sijtsma
LC
,
Rinkel
GJ
,
Ruigrok
YM
.
Sex-related clustering of intracranial aneurysms within families
.
Stroke
.
2015
Apr
;
46
(
4
):
1107
9
.
[PubMed]
0039-2499
11.
Wiebers
DO
,
Whisnant
JP
,
Huston
J
 3rd
,
Meissner
I
,
Brown
RD
 Jr
,
Piepgras
DG
, et al.;
International Study of Unruptured Intracranial Aneurysms Investigators
.
Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment
.
Lancet
.
2003
Jul
;
362
(
9378
):
103
10
.
[PubMed]
0140-6736
12.
Morita
A
,
Kirino
T
,
Hashi
K
,
Aoki
N
,
Fukuhara
S
,
Hashimoto
N
, et al.;
UCAS Japan Investigators
.
The natural course of unruptured cerebral aneurysms in a Japanese cohort
.
N Engl J Med
.
2012
Jun
;
366
(
26
):
2474
82
.
[PubMed]
0028-4793
13.
Hoh
BL
,
Sistrom
CL
,
Firment
CS
,
Fautheree
GL
,
Velat
GJ
,
Whiting
JH
, et al.
Bottleneck factor and height-width ratio: association with ruptured aneurysms in patients with multiple cerebral aneurysms
.
Neurosurgery
.
2007
Oct
;
61
(
4
):
716
22
.
[PubMed]
0148-396X
14.
Harrod
CG
,
Batjer
HH
,
Bendok
BR
.
Deficiencies in estrogen-mediated regulation of cerebrovascular homeostasis may contribute to an increased risk of cerebral aneurysm pathogenesis and rupture in menopausal and postmenopausal women
.
Med Hypotheses
.
2006
;
66
(
4
):
736
56
.
[PubMed]
0306-9877
15.
Longstreth
WT
,
Nelson
LM
,
Koepsell
TD
,
van Belle
G
.
Subarachnoid hemorrhage and hormonal factors in women. A population-based case-control study
.
Ann Intern Med
.
1994
Aug
;
121
(
3
):
168
73
.
[PubMed]
0003-4819
16.
Hademenos
GJ
,
Massoud
TF
,
Turjman
F
,
Sayre
JW
.
Anatomical and morphological factors correlating with rupture of intracranial aneurysms in patients referred for endovascular treatment
.
Neuroradiology
.
1998
Nov
;
40
(
11
):
755
60
.
[PubMed]
0028-3940
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.